EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv)

Deniz Tülümen, Esra Aydemir, Furkan Ayaz

Pharmaceutical Research · 2026

DOI: 10.1007/s11095-025-04002-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Deniz Tülümen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34010, Türkiye. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Viral Vaccines, Hemorrhagic Fever, Crimean, Antigens, Viral. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istinye University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Crimean-Congo hemorrhagic fever virus (CCHFV), identified by the World Health Organization(WHO) as a potential epidemic threat, is a tick-borne Nairovirus primarily transmitted by Hyalomma marginatum species. Since its first detection in the 1940s, CCHFV has spread to multiple regions worldwide and remains a major public health concern due to its high fatality rate and expanding geographic distribution. The virus can be transmitted through tick bites or contact with infected individuals, and no licensed vaccine is currently available to prevent infection.

Methods

In this study, two CCHFV proteins, Q8JSZ3 (GP_CCHFI) and Q6TQR6 (L_CCHFI), were retrieved from public databases and analyzed using bioinformatic tools to explore their potential as vaccine candidates.

Results

The computational analyses revealed that both proteins possess non-toxic characteristics and show promise for future vaccine design.

Conclusions

These findings provide a preliminary in-silico framework that may guide the development of effective vaccines against CCHFV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever Virus, Crimean-CongoViral VaccinesHemorrhagic Fever, CrimeanAntigens, ViralViral ProteinsComputer SimulationAnimalsHumansComputational BiologyAmino Acid Sequence

Stichwörter der Autor:innen

hyalomma marginatumin-silicocrimean-congo hemorrhagic fever virus (CCHFV)vaccine candidates

Substanzen

Viral VaccinesAntigens, ViralViral Proteins

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34010, Türkiye.
  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34010, Türkiye. esra.aydemir81@gmail.com.
  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istinye University, Istanbul, 34010, Türkiye. furkan1988ayaz@gmail.com.

Förderung

  • Istinye University

Zitieren

APA

Tülümen, D., Aydemir, E., & Ayaz, F. (2026). In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv). Pharmaceutical Research. https://doi.org/10.1007/s11095-025-04002-2

Vancouver

Tülümen D, Aydemir E, Ayaz F. In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv). Pharmaceutical Research. 2026. doi:10.1007/s11095-025-04002-2

BibTeX
@article{Tlmen2026,
  author = {Tülümen, Deniz and Aydemir, Esra and Ayaz, Furkan},
  title = {In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv)},
  journal = {Pharmaceutical Research},
  year = {2026},
  doi = {10.1007/s11095-025-04002-2}
}
Kostenlos starten →